SCHEMBL4902932

SCHEMBL4902932

O=c1c(NCc2cc(Br)ccc2O)c(Nc2ccc3[nH]cnc3c2)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
APAF1 O14727 1/20 0.40
ROCK2 O75116 3/20 0.39
ROCK1 Q13464 3/20 0.39
GSK3A P49840 2/20 0.39
JAK2 O60674 2/20 0.39
CHEK2 O96017 2/20 0.39
PRKACA P17612 2/20 0.39
RPS6KA3 P51812 2/20 0.39
PRKCD Q05655 2/20 0.39
PRKAA1 Q13131 2/20 0.39
DYRK1A Q13627 2/20 0.39
CDC42BPA Q5VT25 2/20 0.39
AURKB Q96GD4 2/20 0.39
PRKD2 Q9BZL6 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4898762 0.86 ROCK1 (0.41) CA12CA1CA2CA9ROCK2
SCHEMBL4908588 0.82 QPCT (0.48) ROCK2ROCK1GSK3AJAK2CHEK2
SCHEMBL4902107 0.81 ROCK1 (0.41) ROCK2ROCK1GSK3AJAK2CHEK2
SCHEMBL4598446 0.81 ROCK1 (0.40) ROCK2ROCK1GSK3AJAK2CHEK2
SCHEMBL4898774 0.81 ROCK1 (0.43) ROCK2ROCK1GSK3AJAK2CHEK2
SCHEMBL4905527 0.80 ROCK1 (0.42) MEN1KMT2AROCK2ROCK1GSK3A
SCHEMBL4598260 0.80 ROCK1 (0.47) ROCK2ROCK1GSK3AJAK2CHEK2
SCHEMBL4598611 0.80 ROCK1 (0.42) ROCK2ROCK1GSK3AJAK2CHEK2
SCHEMBL4910893 0.79 ROCK1 (0.47) ROCK2ROCK1GSK3AJAK2CHEK2
SCHEMBL4907489 0.79 ROCK1 (0.39) ROCK2ROCK1GSK3AJAK2CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080234266-A1 Squaric Acid Derivatives II MERCK PATENT GESELLSCHAFT (DE) 2008-09-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080234266-A1 Squaric Acid Derivatives II CHEK2, CHEK1, SGK3 CA12 3689/4885CA1 2225/4885CA2 1394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.